Dexamethasone Treatment for COVID-19 is Related to Increased Mortality in Hematologic Malignancy Patients: Results from the EPICOVIDEHA Registry

Garcia-Vidal C, Moreno-Garcia E, Hernandez-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N . Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis. 2020; 74(1):127-132. PMC: 7454444. DOI: 10.1093/cid/ciaa964. View

Garcia-Vidal C, Alonso R, Camon A, Cardozo C, Albiach L, Aguero D . Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother. 2021; 76(12):3296-3302. PMC: 8499897. DOI: 10.1093/jac/dkab321. View

Aiello T, Puerta-Alcalde P, Chumbita M, Monzo P, Lopera C, Hurtado J . Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19. J Infect. 2022; 85(5):e152-e154. PMC: 9355741. DOI: 10.1016/j.jinf.2022.07.029. View

Hedberg P, Valik J, van der Werff S, Tanushi H, Mendez A, Granath F . Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Thorax. 2021; 77(2):154-163. PMC: 8260304. DOI: 10.1136/thoraxjnl-2021-216949. View

Camon A, Alonso R, Munoz F, Cardozo C, Bernal-Maurandi J, Albiach L . C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19. Sci Rep. 2022; 12(1):5250. PMC: 8960074. DOI: 10.1038/s41598-022-08882-x. View

Mikulska M, Sepulcri C, Dentone C, Magne F, Balletto E, Baldi F . Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients. Clin Infect Dis. 2023; 77(2):280-286. DOI: 10.1093/cid/ciad181. View

. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2023; 401(10387):1499-1507. PMC: 10156147. DOI: 10.1016/S0140-6736(23)00510-X. View

Aiello T, Puerta-Alcalde P, Chumbita M, Lopera C, Monzo P, Cortes A . Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals. J Antimicrob Chemother. 2023; 78(6):1454-1459. DOI: 10.1093/jac/dkad105. View

Sharma A, Bhatt N, Martin A, Abid M, Bloomquist J, Chemaly R . Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021; 8(3):e185-e193. PMC: 7816949. DOI: 10.1016/S2352-3026(20)30429-4. View

10.

Blennow O, Salmanton-Garcia J, Nowak P, Itri F, van Doesum J, Lopez-Garcia A . Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report. Am J Hematol. 2022; 97(8):E312-E317. PMC: 9349555. DOI: 10.1002/ajh.26626. View

11.

Salmanton-Garcia J, Marchesi F, Gomes Da Silva M, Farina F, Davila-Valls J, Bilgin Y . Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. EClinicalMedicine. 2023; 58:101939. PMC: 10078172. DOI: 10.1016/j.eclinm.2023.101939. View

12.

Cesaro S, Ljungman P, Mikulska M, Hirsch H, von Lilienfeld-Toal M, Cordonnier C . Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022; 36(6):1467-1480. PMC: 9053562. DOI: 10.1038/s41375-022-01578-1. View

13.

Vijenthira A, Gong I, Fox T, Booth S, Cook G, Fattizzo B . Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020; 136(25):2881-2892. PMC: 7746126. DOI: 10.1182/blood.2020008824. View

14.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

15.

Pan H, Peto R, Henao-Restrepo A, Preziosi M, Sathiyamoorthy V, Abdool Karim Q . Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2020; 384(6):497-511. PMC: 7727327. DOI: 10.1056/NEJMoa2023184. View